Nia Therapeutics, Inc. — SEC Form D Filing
Nia Therapeutics, Inc. filed an SEC Form D on March 6, 2026, reporting $18.84M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- March 6, 2026
- Amount reported
- $18.84M
- Round stage
- Seed
- Industry
- Health Care
- Website
- https://niatherapeutics.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Nia Therapeutics addresses the issue of memory loss affecting 27 million Americans through innovative treatments.
Solution
They provide closed-loop brain stimulation technology to enhance memory and cognitive function.
Why now
With an increasing number of individuals experiencing cognitive disorders, there is a timely need for innovative treatment solutions.
Verdict
Investors supported Nia Therapeutics because the narrative around brain-computer interface solutions for memory loss was timely, not because traditional treatments yielded high confidence in efficacy. This cleared because the increasing prevalence of cognitive disorders provided a convincing market signal, not because there was a proven demand for Nia’s specific technology. Implicitly, investors bet on a rapidly evolving sector, but the limited upside comes from potential regulatory hurdles and a lack of established adoption in clinical settings.
Source: SEC EDGAR Form D filing